Deutsche Bank Ag\ Ptc Therapeutics, Inc. Transaction History
Deutsche Bank Ag\
- $240 Billion
- Q3 2024
A detailed history of Deutsche Bank Ag\ transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 49,068 shares of PTCT stock, worth $2.23 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,068
Previous 38,854
26.29%
Holding current value
$2.23 Million
Previous $1.19 Million
53.2%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding PTCT
# of Institutions
222Shares Held
78.1MCall Options Held
144KPut Options Held
58.7K-
Vanguard Group Inc Valley Forge, PA9.13MShares$415 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$359 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$353 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$336 Million4.37% of portfolio
-
Armistice Capital, LLC New York, NY7.23MShares$329 Million4.46% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.25B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...